Device Compression

Jobst Formen Ambition

Payments companies reported to CMS as associated with Jobst Formen Ambition. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,512associated payments (2023-2025)

36clinicians with associated payments

1company reporting

By year

2023 $4,512

Payments reported as associated with Jobst Formen Ambition, per program year, as reported to CMS.

Who makes it

Bsn Medical INC $4,512 associated with Jobst Formen Ambition (2023-2025)

Specialties most often involved

Vascular Surgery $1,370

Vascular & Interventional Radiology $553

Family $403

Physician Assistant $386

Infectious Disease $335

Foot & Ankle Surgery $273

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Jobst Formen Ambition

These are the largest totals companies reported as associated with Jobst Formen Ambition. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Laura Hoffman	Atlanta, GA	Family	$280.93
Morris Stribling	San Antonio, TX	Foot & Ankle Surgery	$273.00
Lyssa Ochoa	San Antonio, TX	Vascular Surgery	$270.14
Thomas Gianis	San Antonio, TX	Vascular Surgery	$270.14
Inocencia Carrano	Middletown, NY	Spinal Cord Injury Medicine	$239.50
Michael Di Iorio	Austin, TX	Vascular & Interventional Radiology	$236.61
Ryan Greene	Indianapolis, IN	Vascular & Interventional Radiology	$221.88
Haseeb Ali	San Antonio, TX	Physician Assistant	$186.48
Dhiresh Joshi	Las Vegas, NV	Infectious Disease	$174.14
Taras Vysotskyy	Ronkonkoma, NY	Podiatrist	$168.56

Prescribed Jobst Formen Ambition?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.